Ceribell, Inc

Ceribell, Inc. is a medical technology company that develops point-of-care electroencephalography (EEG) platforms for acute care settings, including emergency departments and intensive care units. The company builds hardware and software systems designed to triage and continuously monitor hospital patients at risk for seizures and delirium. Its offerings include a dual seizure and delirium monitoring platform and the Clarity system, an FDA-cleared seizure detection algorithm for newborns and older patients.

Ceribell serves clinicians, neurologists, neurocritical care specialists, nurses, and hospital facilities by facilitating rapid bedside assessment and treatment of non-convulsive seizures. The company incorporates artificial intelligence and machine learning technologies into its diagnostic products, utilizing AI-powered algorithms for seizure detection and status epilepticus identification. Its platform combines portable hardware with software to assist medical professionals in evaluating patients and managing neurological conditions in clinical environments.